FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285014721> ?p ?o ?g. }

• W4285014721 abstract "Pulmonary thromboembolism is a common disease frequently encountered in the emergency room and has a high mortality rate. Antiphospholipid syndrome (APS) is a high-risk factor for recurrent pulmonary embolism (PE). It is critical to effectively administer anticoagulants to avoid the recurrence of thrombotic events. This study aims to identify the clinical characteristics of APS patients with PE (APS-PE) and to develop a risk score for determining the presence of APS in PE patients in the emergency situations.We retrospectively enrolled 76 PE patients in this study, with 46 patients in the APS-PE group and 30 patients in the non-APS-PE group. We compared differences in demographics, laboratory parameters, and early mortality risk between the two groups. Risk factors for APS-PE were screened using logistic regression analysis. We also developed an early risk score using multivariate analysis weighted points proportional to the β- regression coefficient values and calculated the sensitivity and specificity for APS in PE patients.In the APS-PE group, we observed a higher proportion of males (43.6 vs. 20%), a higher proportion of low-risk patients (58.7 vs. 10%), lower levels of white blood cells and platelets (PLT), longer activated partial thromboplastin time (APTT), and a slight increase in D-dimer levels. Patients who were triple positive for antiphospholipid antibodies (aPLs) were younger. The APTT gradually increased as the number of positive aPLs increased. The risk factors for APS included male (OR = 5.565, 95% CI 1.176-26.341), decreased PLT (OR = 0.029, 95% CI 0.003-0.330), slightly increased D-dimer (OR = 0.089, 95% CI 0.019-0.426), and prolonged APTT (OR = 4.870, 95% CI 1.189-19.951). The risk score was named MPDA and included male, PLT, D-dimer and APTT, which can predict APS in PE patients with the AUC at 0.888 (95% CI 0.811-0.965).The risk factors for APS in PE patients are male, low PLT, prolonged APTT and slightly increased D-dimer. The MPDA is a quantitative scoring system which is highly suggestive of APS in PE patients." @default.
• W4285014721 created "2022-07-12" @default.
• W4285014721 creator A5003825023 @default.
• W4285014721 creator A5018620403 @default.
• W4285014721 creator A5022553731 @default.
• W4285014721 creator A5034711601 @default.
• W4285014721 creator A5044420808 @default.
• W4285014721 creator A5081427229 @default.
• W4285014721 creator A5087211309 @default.
• W4285014721 date "2022-07-11" @default.
• W4285014721 modified "2023-10-01" @default.
• W4285014721 title "Antiphospholipid Syndrome-Related Pulmonary Embolism: Clinical Characteristics and Early Recognition" @default.
• W4285014721 cites W1969171402 @default.
• W4285014721 cites W1980461685 @default.
• W4285014721 cites W1992631495 @default.
• W4285014721 cites W1994024608 @default.
• W4285014721 cites W2012846263 @default.
• W4285014721 cites W2017573410 @default.
• W4285014721 cites W2019242730 @default.
• W4285014721 cites W2039525222 @default.
• W4285014721 cites W2042958596 @default.
• W4285014721 cites W2054330426 @default.
• W4285014721 cites W2055282464 @default.
• W4285014721 cites W2058464136 @default.
• W4285014721 cites W2069797332 @default.
• W4285014721 cites W2113738930 @default.
• W4285014721 cites W2127565509 @default.
• W4285014721 cites W2148882122 @default.
• W4285014721 cites W2159072407 @default.
• W4285014721 cites W2170419612 @default.
• W4285014721 cites W2242827060 @default.
• W4285014721 cites W2335439615 @default.
• W4285014721 cites W2581064851 @default.
• W4285014721 cites W2582359736 @default.
• W4285014721 cites W2619702657 @default.
• W4285014721 cites W2732585785 @default.
• W4285014721 cites W2783176674 @default.
• W4285014721 cites W2784285632 @default.
• W4285014721 cites W2791992225 @default.
• W4285014721 cites W2793259357 @default.
• W4285014721 cites W2803799996 @default.
• W4285014721 cites W2894608536 @default.
• W4285014721 cites W2906361717 @default.
• W4285014721 cites W2921658342 @default.
• W4285014721 cites W2943123864 @default.
• W4285014721 cites W2970101385 @default.
• W4285014721 cites W3011400883 @default.
• W4285014721 cites W3096784218 @default.
• W4285014721 cites W3167421149 @default.
• W4285014721 cites W3180022368 @default.
• W4285014721 cites W4210593746 @default.
• W4285014721 cites W4255873166 @default.
• W4285014721 cites W6072419 @default.
• W4285014721 doi "https://doi.org/10.3389/fcvm.2022.872523" @default.
• W4285014721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35898271" @default.
• W4285014721 hasPublicationYear "2022" @default.
• W4285014721 type Work @default.
• W4285014721 citedByCount "3" @default.
• W4285014721 countsByYear W42850147212023 @default.
• W4285014721 crossrefType "journal-article" @default.
• W4285014721 hasAuthorship W4285014721A5003825023 @default.
• W4285014721 hasAuthorship W4285014721A5018620403 @default.
• W4285014721 hasAuthorship W4285014721A5022553731 @default.
• W4285014721 hasAuthorship W4285014721A5034711601 @default.
• W4285014721 hasAuthorship W4285014721A5044420808 @default.
• W4285014721 hasAuthorship W4285014721A5081427229 @default.
• W4285014721 hasAuthorship W4285014721A5087211309 @default.
• W4285014721 hasBestOaLocation W42850147211 @default.
• W4285014721 hasConcept C126322002 @default.
• W4285014721 hasConcept C151956035 @default.
• W4285014721 hasConcept C2776265017 @default.
• W4285014721 hasConcept C2776874634 @default.
• W4285014721 hasConcept C2778261982 @default.
• W4285014721 hasConcept C2778959117 @default.
• W4285014721 hasConcept C2779519742 @default.
• W4285014721 hasConcept C2780868729 @default.
• W4285014721 hasConcept C71924100 @default.
• W4285014721 hasConcept C89560881 @default.
• W4285014721 hasConcept C90924648 @default.
• W4285014721 hasConceptScore W4285014721C126322002 @default.
• W4285014721 hasConceptScore W4285014721C151956035 @default.
• W4285014721 hasConceptScore W4285014721C2776265017 @default.
• W4285014721 hasConceptScore W4285014721C2776874634 @default.
• W4285014721 hasConceptScore W4285014721C2778261982 @default.
• W4285014721 hasConceptScore W4285014721C2778959117 @default.
• W4285014721 hasConceptScore W4285014721C2779519742 @default.
• W4285014721 hasConceptScore W4285014721C2780868729 @default.
• W4285014721 hasConceptScore W4285014721C71924100 @default.
• W4285014721 hasConceptScore W4285014721C89560881 @default.
• W4285014721 hasConceptScore W4285014721C90924648 @default.
• W4285014721 hasLocation W42850147211 @default.
• W4285014721 hasLocation W42850147212 @default.
• W4285014721 hasLocation W42850147213 @default.
• W4285014721 hasOpenAccess W4285014721 @default.
• W4285014721 hasPrimaryLocation W42850147211 @default.
• W4285014721 hasRelatedWork W184771463 @default.
• W4285014721 hasRelatedWork W2005290673 @default.
• W4285014721 hasRelatedWork W2015851887 @default.
• W4285014721 hasRelatedWork W2324209608 @default.
• W4285014721 hasRelatedWork W2415982798 @default.

• next